International Symposium on Amyloidosis

This gathering of leading experts in the field of amyloidosis is held biennially at different locations around the world. This year, the four-day meeting was held in Heidelberg, Germany and comprised 25 lectures, 71 oral presentations, 309 poster presentations and 8 satellite symposia. There was notable growth in the number of participants and their countries […]

National Doctor’s Day

Today is National Doctors’ Day, and we’d like to take a moment to say thank you to the incredible physicians that make up our Multidisciplinary Team at the BU Amyloidosis Center! #nationaldoctorsday #amyloidosis

Congratulations Dr. Siddiqi!

The outstanding service of Dr. Omar Siddiqi has been honored by The Boston University School of Medicine with the “Educator of the Year” award!  Congratulations Dr. Siddiqi!

Intellia’s first CRISPR gene editing therapy shows promise in small study

“Intellia Therapeutics has moved one step closer to its ambition of creating one-and-done gene-editing treatments for people with genetic diseases. Last August, the Cambridge company and its partner, Regeneron Pharmaceuticals, published a landmark study showing that even low doses of their one-time treatment based on CRISPR-Cas9 technology could dramatically reduce levels of a disease-causing protein […]

Amyloidosis Foundation Grant!

Congratulations to Dr. K. H. Vincent Lau and mentor Dr. Vaishali Sanchorawala on their Amyloidosis Foundation Grant award, announced by the foundation on January 31, 2022! Their project “Evaluating Plasma Neurofilament Light Chain as an Early Biomarker for Polyneuropathy in V122I Hereditary Transthyretin Amyloidosis” aims to characterize a blood marker for early detection of neuropathy, […]